Skip to main content
ConductScienceScienceDex

Robert C Rostomily

FY2026 NIH rank #16,794
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1905210Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$1.2M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#16,794
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Robert C Rostomily. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$621.8K

2 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Robert C Rostomily as a PI. Multi-PI records show the full award amount for context.

  • 5R01NS129720-04R01
    “Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response”
    Houston Methodist Research Institute
    $552.1K
    award amount
  • 1R42CA302217-01A1R42
    Development and Validation of Orthotopic Oncopig Glioma Models for Preclinical Locoregional Therapeutic Evaluation
    Sus Clinicals, Inc.
    $400K
    award amount
  • 5R61CA278458-03R61
    A multiplexed high-throughput platform to report pharmacologic alteration of cancer stem cell membrane potential and cell cycle state
    Houston Methodist Research Institute
    $221.8K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Robert C Rostomily as a PI.

Houston Methodist Research Institute
TX
$774K
2 grants
Sus Clinicals, Inc.
OH
$400K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Houston Methodist Research Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5415
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Robert C Rostomily.

Andrei M Mikheev
Houston Methodist Research Institute
3
shared awards
Francois St-pierre
Houston Methodist Research Institute
3
shared awards
Stephen H. Safe
Houston Methodist Research Institute
3
shared awards
Philip J Horner
Houston Methodist Research Institute
2
shared awards
Karol Bomsztyk
University of Washington
1
shared award
Kyle Schachtschneider
Sus Clinicals, Inc.
1
shared award
Lawrence B. Schook
Sus Clinicals, Inc.
1
shared award
Monika Vishnoi
Houston Methodist Research Institute
1
shared award
Monika Vishnoi
Sus Clinicals, Inc.
1
shared award

Explore further

Find collaborators for Robert C Rostomily

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →